Abstract
The aim of this chapter is to sensitise the reader to the precautions to take when miniaturising a screening assay and when interpreting the results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
DREWS J. (2000) Drug discovery: a historical perspective. Science 287: 1960-1964
EGGELING C., BRAND L., ULLMANN D., JAGER S. (2003) Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov. Today 8: 632-641
SEETHALA R., FERNANDES P.B. (2001) Handbook of drug screening. New York-Basel, Marcel Dekker inc.
FERNANDES P.B. (1998) Technological advances in high throughput screening. Curr. Opin. Chem. Biol. 2: 597-603
FOX S., WANG H., SOPCHAK L., FARR-JONES S. (2002) High throughput screening 2002: moving toward increased success rates. J. Biomol. Screen. 7: 313-316
GOPALAKRISHNAN S.M., MAMMEN B., SCHMIDT M., OTTERSTAETTER B., AMBERG W., WERNET W., KOFRON J.L., BURNS D.J., WARRIOR U. (2005) An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR. J. Biomol. Screen. 10: 46-55
HAGGARTY S.J., MAYER T.U., MIYAMOTO D.T., FATHI R., KING R.W., MITCHISON T.J., SCHREIBER S.L. (2000) Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem. Biol. 7: 275-286
HERTZBERG R.P., POPE A.J. (2000) High throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4: 445-451
HORROCKS C., HALSE R., SUZUKI R., SHEPHERD P.R. (2003) Human cell systems for drug discovery. Curr. Opin. Drug Discov. Dev. 6(4): 570-575.
HUBERT C.L., SHERLING S.E., JOHNSTON P.A., STANCATO L.F. (2003) Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J. Biomol. Screen. 8: 399-409
JAGER S., BRAND L., EGGELING C. (2003) New fluorescence techniques for high-throughput drug discovery. Curr. Pharm. Biotechnol. 4: 463-76.
JOHNSTON P.A., JOHNSTON P.A. (2002) Cellular platforms for HTS: three case studies. Drug Discov. Today 7: 353-363
KEMP D.M., GEORGE S.E., KENT T.C., BUNGAY P.J., NAYLOR L.H. (2002) The effect of ICER on screening methods involving CRE-mediated reporter gene expression. J. Biomol. Screen. 7: 141-148
KNOCKAERT M., GREENGARD P., MEIJER L. (2002b) Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23: 417-425
KNOCKAERT M., WIEKING K., SCHMITT S., LEOST M., GRANT K.M., MOTTRAM J.C., KUNICK C. MEIJER L. (2002a) Intracellular targets of paullones: identification following affinity purification on immobilized inhibitor. J. Biol. Chem. 277: 25493-25501
KNOCKAERT M., MEIJER L. (2002) Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography. Biochem. Pharmacol. 64: 819-25
MCGOVERN S.L., CASELLI E., GRIGORIEFF N., SHOICHET B.K. (2002) A common mechanism underlying promiscuous inhibition from virtual and high-throughput screening. J. Med. Chem. 45: 1712-1722
MOORE K., REES S. (2001) Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screen. 6: 69-74
REVAH F. (2002) La révolution du médicament: de 1040 à 10 molécules. Sciences et Vie 218: 18-27
SILLS M.A., WEISS D., PHAM Q., SCHWEITZER R., WU X, WU J.J. (2002) Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J. Biomol. Screen. 7: 191-214
STOCKWELL B.R. (2000) Frontiers in chemical genetics. Trends Biotechnol. 18: 449-455
STOCKWELL B.R., HAGGARTY S.J., SCHREIBER S.L. (1999) High throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6: 71-83
SULLIVAN E., TUCKER E.M., DALE I.L. (1999) Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR). Methods Mol. Biol. 114: 125-133
VON LEOPRECHTING A., KUMPF R., MENZEL S., REULLE D., GRIEBEL R., VALLER M.J., BUTTNER F.H. (2004) Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform. J. Biomol. Screen. 9: 719-725
WILLIAMS C. (2004) cAMP detection methods in HTS: selecting the best from the rest. Nat. Rev. Drug Discov. 3: 125-135
WU G., YUAN Y., HODGE C.N. (2003) Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. J. Biomol. Screen. 8: 694-700
YOUNG K.H., WANG Y., BENDER C., AJIT S., RAMIREZ F., GILBERT A., NIEUWENHUIJSEN B.W. (2004) Yeast-based screening for inhibitors of RGS proteins. Methods Enzymol. 389: 277-301
YOUNG K., LIN S., SUN L., LEE E., MODI M., HELLINGS S., HUSBANDS M., OZENBERGER B., FRANCO R. (1998) Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat. Biotechnol. 16: 946-950
ZHANG J.H., CHUNG T.D., OLDENBURG K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4: 67-73
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Knibiehler, M. (2011). The miniaturised biological assay: constraints and limitations. In: MARECHAL, E., Roy, S., Lafanechère, L. (eds) Chemogenomics and Chemical Genetics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19615-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-19615-7_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19614-0
Online ISBN: 978-3-642-19615-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)